{"public_id":"cl_0097f69df8d5233f676d43a8e0661b25","status":"active","superseded_by_public_id":null,"corpus_id":35107128,"text":"The comparative immunogenicity assessment did not show a clear efficacy advantage for either infant immunization schedule.","confidence":0.74,"paper":{"corpus_id":35107128,"title":"Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules.","url":"https://sah.borca.ai/papers/35107128"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.74,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_7b88dd351a4f276ed9b9f7475d242403","name":"3-dose primary series","description":"An infant immunization schedule consisting of three primary doses.","types":["immunization schedule"],"url":"https://sah.borca.ai/concepts/co_7b88dd351a4f276ed9b9f7475d242403"},{"public_id":"co_88e5cb61983a46e8a922039a75b27b64","name":"4-dose series","description":"An infant immunization schedule consisting of four primary doses.","types":["immunization schedule"],"url":"https://sah.borca.ai/concepts/co_88e5cb61983a46e8a922039a75b27b64"},{"public_id":"co_d81a10719295a0d4830c22def42aa29d","name":"trivalent oral poliovirus vaccine","description":"An oral poliovirus vaccine formulation that targets all three poliovirus serotypes.","types":["vaccine"],"url":"https://sah.borca.ai/concepts/co_d81a10719295a0d4830c22def42aa29d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_0097f69df8d5233f676d43a8e0661b25"}